Another Major Study on Adverse Events in the Ambulatory Setting Hepatotoxicity Caused by Angiotensin II Receptor Blockers Interferon Alfa Therapy and Psychosis Priapism with an Atypical Antipsychotic Update on Drug-Induced Thrombocytopenia
Restricted accessResearch articleFirst published online May, 2003
Another Major Study on Adverse Events in the Ambulatory Setting Hepatotoxicity Caused by Angiotensin II Receptor Blockers Interferon Alfa Therapy and Psychosis Priapism with an Atypical Antipsychotic Update on Drug-Induced Thrombocytopenia
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
Get full access to this article
View all access options for this article.
References
1.
ShusterJ.ISMP adverse drug reactions.Hosp Pharm.2003; 38: 199–201, 270.
2.
GurwitzJ.H., FieldT.S., HarroldL.R.Incidence and preventability of adverse drug events among older persons in the ambulatory setting.JAMA.2003; 289: 1107–16.
3.
ClassenD.Medication safety: Moving from illusion to reality [editorial].JAMA.2003; 289: 1154–6.
4.
BasileG., VillariD., GangemiS.Candesartan cilexitil-induced severe hepatotoxicity.J Clin Gastrenterol.2003; 36: 273–5.
5.
KiykimA., AltintasE., SezginO.Valsartan-induced hepatotoxicity in a HBs-Ag-positive patient [letter].Amer J Gastroenterol.2003; 98: 507.
6.
TamamL., YerdelenD., OzpoyrazN.Psychosis associated with interferon alfa therapy for chronic hepatitis B.Ann Pharmacother.2003; 37: 384–7.
7.
BourgeoisJ.A., MundhH.Priapism associated with risperidone: A case report [letter].J Clin Psych.2003; 64: 218–9.
